Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022
Rhea-AI Summary
Societal CDMO (NASDAQ: SCTL) will release its financial results for Q1 2022 on May 11, 2022, after market close. The company specializes in complex formulation and manufacturing challenges in small molecule therapeutics. A conference call and audio webcast will follow at 4:30 p.m. ET to discuss the results and operational highlights. Interested parties can access the call via phone or through the company’s website. An archived version will be available for 30 days post-event.
Positive
- None.
Negative
- None.
News Market Reaction – SCTL
On the day this news was published, SCTL gained 1.55%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Conference Call and Webcast Scheduled for Wednesday, May 11, 2022, at 4:30 p.m. Eastern
SAN DIEGO and GAINESVILLE, Ga., May 04, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will release financial results for the first quarter 2022 after the market close on Wednesday, May 11, 2022. Societal’s management team will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, May 11, 2022, to discuss the financial results and recent operational highlights.
To access the live conference call please dial (844) 243-4691 from the U.S. or (225) 283-0379 from outside the U.S. at least ten minutes prior to the start time and reference conference ID 1524549. Those interested in listening to the conference call live via webcast may do so by visiting the “Events” page in the Investor section of the Company’s website, www.societalcdmo.com. In addition, an archived webcast will be available on the Company’s website approximately two hours after the event and will be available for 30 days.
About Societal CDMO
Societal CDMO (NASDAQ: SCTL) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal CDMO is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.
In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, which total 145,000 square feet, in Gainesville, Georgia and San Diego, California.
Societal CDMO: Bringing Science to Society. For more information about Societal CDMO’s customer solutions, visit societalcdmo.com.
FAQ
When will Societal CDMO release its Q1 2022 financial results?
What time is the conference call for Societal CDMO's financial results?
How can I listen to Societal CDMO's conference call?
Is there an archived version of Societal CDMO's conference call available?
